Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Affymetrix, Inc.    AFFX   US00826T1088

AFFYMETRIX, INC. (AFFX)

18
SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops, manufactures and sells products and services for genetic analysis

Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level.

It develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets.

Affymetri sells products to some of pharmaceutical, diagnostic and biotechnology companies, as well as leading academic, government and not-for-profit research institutions.

The company operates through two segments: Affymetrix Core and eBioscience.

The Affymetrix Core segment is divided into three business units, namely Expression, Genetic Analysis and Clinical Applications and Life Science Reagents.

The Expression business unit develops and markets the company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products.

The Genetic Analysis and Clinical Applications business unit develops and markets the company's genotyping, such as the Axiom product line and arrays with clinical research applications, such as the CytoScan cytogenetics arrays.

The Life Science Reagents business unit develops and sells reagents, enzymes, purification kits and biochemical's used by life science researchers.

The eBioscience segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses.

It operates in one business unit i.e., Corporate business, which is comprised primarily of revenue from royalty arrangements, and field revenue from services provided to customers by the company.

The company was founded by Stephen P. A. Fodor in 1991 and is headquartered in Santa Clara, CA.
Sales per Businesses
20122013Delta
USD (in Million)%USD (in Million)%
Affymetrix Core235.1179.5%252.1676.5% +6.77%
eBioscience37.0112.5%78.2423.7% +52.69%
Other Revenue23.518%---
Sales per Regions
20122013Delta
USD (in Million)%USD (in Million)%
United States171.1857.9%202.3261.4% +15.39%
Europe71.5324.2%80.8424.5% +11.53%
Other31.8810.8%31.729.6% -0.51%
Japan21.047.1%15.514.7% -35.64%
Singapore-----
Surperformance© rating of Affymetrix, Inc.
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
PER - - -
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Advertisement
Sector Biotechnology
Trading RatingInvestor Rating
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN IDEC INC
CELGENE CORPORATI..
CSL LIMITED
Sector Biotechnology
Company contact information
Affymetrix, Inc.
3420 Central Expressway
Santa Clara, CA 95051

Phone : +1.408.731.5000
Fax : +1.408.731.5380
Web : www.affymetrix.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF